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Introduction: Awareness and knowledge are important aspects of VAP 
prevention program. The participants have fair knowledge in VAP and VAP 
prevention. However, being knowledgeable does not assure implementation of 
evidence-based guideline, and guidelines adherence require the readiness to sustain 
that changed behavior. 
 
Objective: Study objective is to determine the effect of VAP-bundle 
educational program on nurses’ knowledge, practice, and incidence rate as well as 
factors associated with ventilator-associated pneumonia in ICU. 
 
Materials and methods: A prospective study on VAP was conducted in ICU 
with two study groups, ICU nurses and patients who are ventilated for 48 hours or 
more. Nurses who consented were subjected to self-administered questionnaire 
before and after VAP-bundle educational program. While patient’s data before and 
after was collected from their medical records from early 2009 to early 2011. VAP 
was diagnosed based on Central for Disease Control and Prevention (CDC). The 
definition used for diagnosis was based on clinical and organisms isolated from 
tracheal aspirate. 
 
Result and discussion: Pre and post-intervention mean and standard 
deviation of participants score were fair but were significant different pre compared to 
post-intervention, [56.11 (2.82), 62.19 (2.70), mean score difference: 6.07 (4.95, 
7.20) 95% CI, p < 0.001] respectively. Meanwhile the pre-intervention VAP rates 
were found to be reduced from 17.3 episodes per 1,000 ventilator-days to 7.0 
episodes per 1,000 ventilator-days. The reduction rate was 59.5% but no significant 
association with VAP bundle interventions. It is associated with increased of the 
nurses’ skills in delivering of care related to oral care practices, maintaining of 
endotracheal tube cuff pressure, performing meticulous hands hygiene and infection 
control. After adjusting for cofounder, multiple logistic regression revealed that 
patients who undergo intrahospital transport are 7.2 times at risk to develop VAP 
compared to non-transport patients [Adjusted OR: 7.2, 95% CI: 2.46, 21.28, p < 
0.001]. The main reasons for intrahospital transport were computed tomography 
scanning, and surgery. Meanwhile patients who have renal insufficiency are 5.7 
times at risk to develop VAP [Adjusted OR: 5.7, 95% CI: 1.77, 18.84, p = 0.004]. 
Hortal et al. (2009) reported that patients who have creatinine levels of > 1.5 mg/dl 
were at risk to develop VAP. It is crucial to provide regular continuous nursing 
education program for at least 3-4 times a year to increase nurses’ awareness and 
knowledge on VAP prevention strategies. It is essential to explore the factors that 
contribute to the development of VAP for patients who have renal insufficiency and 
undergo intrahospital transportation in the ICU. 
 
Conclusion: There were significant reductions in VAP rate after intervention 
period. However the nurses’ knowledge on VAP and the prevention strategies were 
inadequate. Intrahospital transport and patient with renal insufficiency are more at 
risk to develop VAP. 
 
Keywords: nurses’ knowledge, ventilator-associated pneumonia, rate of 
ventilator-associated pneumonia, intrahospital transport, and renal insufficiency 
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VENTILATOR-ASSOCIATED PNEUMONIA (VAP) DI UNIT RAWATAN 
INTENSIF: PERANAN PENDIDIKAN VAP BUNDLE DALAM                 
MENGURANGKAN KADARNYA 
ABSTRAK 
Pengenalan: Kesedaran dan pengetahuan adalah aspek penting dalam 
program pencegahan VAP.  Pengetahuan peserta kajian tentang VAP 
dan pencegahannya adalah sederhana. Walaubagaimanapun, 
pengetahuan tidak memastikan amalan mengikut garispanduan saintifik 
dan implementasi garispanduan memerlukan perubahan dan kelestarian. 
Objektif kajian: Memastikan kesan program pendidikan VAP bundle ke 
atas pengetahuan serta amalan jururawat dan kadar insiden serta faktor 
yang berkaitan dengan VAP di ICU.  
Bahan dan kaedah kajian: Kajian prospektif dijalankan di ICU dengan dua 
kumpulan kajian, jururawat ICU dan pesakit yang menerima bantuan 
pernafasan 48 jam atau lebih.  Jururawat dalam kajian dikehendaki 
mengisi borang soal selidik sebelum dan selepas program pendidikan 
VAP bundle.  Data pesakit diambil dari rekod perubatan pesakit sebelum 
dan selepas program pendidikan VAP bundle pada awal tahun 2009 
sehingga awal tahun 2011.  Definisi VAP adalah dirujuk dari Central for 
Disease Control and Prevention (CDC).  Diagnosis VAP yang digunakan 
dalam kajian adalah pengesahkan klinikal dan organisma dari aspirasi 
trakea. 
Keputusan kajian dan perbincangan: Skor min sebelum dan selepas serta 
sisihan piawai peserta adalah sederhana, tetapi terdapat perbezaan yang 
signifikan jika dibandingkan di antara sebelum dengan selepas program 
xii 
 
pendidikan VAP bundle [56.11(2.82), 62.19 (2.70), perbezaan skor min: 
6.07 (4.95, 7.20) CI: 95% p < 0.001] mengikut urutan.  
Walaubagaimanapun, skor ini adalah lebih rendah berbanding peratus 
jawapan betul bagi hospital di Thailand, sebelum [62.19, SD:  2.72] dan 
selepas [78.5%, SD: 10.2%] (Apisarnthanarak et al., 2007), tetapi jauh 
lebih tinggi berbanding hospital di Ghent 41.2% (Blot, Labeau, Vandijck, 
Van Aken & Clae, 2007).  Kadar VAP berkurangan selepas intervensi iaitu 
daripada 17.3 episod setiap 1,000 hari-ventilator  kepada  7.0 episod 
setiap 1,000 hari-ventilator selepas intervensi.  Penurunan kadar VAP 
adalah sebanyak 59.5% tetapi tidak signifikan dan tidak berkaitan dengan 
intervensi VAP bundle.  Hal ini adalah berkaitan dengan peningkatan 
kemahiran jururawat dalam memberi perawatan berkaitan dengan 
penjagaan oral, pemantauan kuf tiub endotrakea, cucian tangan dan 
pengawalan jangkitan. Selepas penyelarasan terhadap faktor menganggu 
(cofounder) regresi logistik pelbagai membuktikan pesakit ICU yang di 
transport intrahospital adalah 7.2 kali ganda berisiko mendapat VAP 
berbanding pesakit yang tidak. Sebab utama pesakit yang perlukan 
transport intrahospital adalah untuk menjalani skan tomografi 
berkomputer dan pembedahan. Bukti ini selaras dengan kajian oleh Kollef 
et al. (1997) dan Bercaualt et al. (2005).  Manakala pesakit yang ada 
masalah renal insufficiency adalah 5.7 berisiko mendapat VAP [Adjusted 
OR: 5.7, 95% CI: 1.77, 18.84, p = 0.004].  Hortal et al. (2009) melaporkan 
bahawa pesakit yang mempunyai serum kretinin > 1.5 mg/dl berisiko 
mendapat VAP. Menambahkan bilangan program pendidikan 
kejururawatan sekurang-kurangnya 3-4 kali setahun bagi meningkatkan 
xiii 
 
kesedaran dan pengetahuan jururawat tentang strategi pencegahan VAP 
adalah perkara paling utama yang perlu dititik beratkan.  Satu kajian juga 
diperlukan untuk meneroka faktor penyumbang terhadap VAP dalam 
kalangan pesakit di ICU yang mengalami renal insufficiency dan pesakit 
yang perlukan transport intrahospital di ICU. 
Kesimpulan: Pengetahuan jururawat tentang VAP dan strategi 
pencegahannya adalah tidak mencukupi. Penurunan kadar VAP adalah 
59.9%, iaitu dari 17.3 kepada 7 episodes per 1,000 hari-ventilator.  
Pesakit di ICU yang menjalani transport intrahospital dan pesakit yang 
mempunyai masalah  renal insufficiency  adalah  berisiko mendapat VAP 
berbanding dengan pesakit lain  
Kata kunci: pengetahuan jururawat, ventilator-associated pneumonia, 
kadar ventilator-associated pneumonia, transport intrahospital, renal 
insufficiency. 
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VENTILATOR-ASSOCIATED PNEUMONIA (VAP) IN INTENSIVE CARE 
UNIT: THE ROLE OF VAP BUNDLE EDUCATION  
IN REDUCING ITS RATES 
ABSTRACT	
Introduction: Awareness and knowledge are important aspects of VAP 
prevention program. The participants have fair knowledge in VAP and 
VAP prevention. However, being knowledgeable does not assure 
implementation of evidence-based guideline, and guidelines adherence 
require the readiness to sustain that changed behavior.   
Study objective is to determine the effect of VAP-bundle educational 
program on nurses’ knowledge, practice, and incidence rate as well as 
factors associated with ventilator-associated pneumonia in ICU. 
Materials and methods: A prospective study on VAP was conducted in 
ICU with two study groups, ICU nurses and patients who are ventilated for 
48 hours or more.  Nurses who consented were subjected to self-
administered questionnaire before and after VAP-bundle educational 
program.  While patient’s data before and after was collected from their 
medical records from early 2009 to early 2011.  VAP was diagnosed 
based on Central for Disease Control and Prevention (CDC). The 
definition used for diagnosis was based on clinical and organisms isolated 
from tracheal aspirate.  
Result and discussion: Pre and post-intervention mean and standard 
deviation of participants score were fair but were significant different pre 
compared to post-intervention, [56.11 (2.82), 62.19 (2.70), mean score 
difference: 6.07 (4.95, 7.20) 95% CI, p < 0.001] respectively.  Meanwhile 
the pre-intervention VAP rates were found to be reduced from 17.3 
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episodes per 1,000 ventilator-days to 7.0 episodes per 1,000 ventilator-
days.  The reduction rate was 59.5% but no significant association with 
VAP bundle interventions.  It is associated with increased of the nurses’ 
skills in delivering of care related to oral care practices, maintaining of 
endotracheal tube cuff pressure, performing meticulous hands hygiene 
and infection control.  After adjusting for cofounder, multiple logistic 
regression revealed that patients who undergo intrahospital transport are 
7.2 times at risk to develop VAP compared to non-transport patients 
[Adjusted OR: 7.2, 95% CI: 2.46, 21.28, p < 0.001].  The main reasons for 
intrahospital transport were computed tomography scanning, and surgery.  
Meanwhile patients who have renal insufficiency are 5.7 times at risk to 
develop VAP [Adjusted OR: 5.7, 95% CI: 1.77, 18.84, p = 0.004].  Hortal 
et al. (2009) reported that patients who have creatinine levels of > 1.5 
mg/dl were at risk to develop VAP (Hortal, Giannella, Pe'rez, et al., 2009). 
It is crucial to provide regular continuous nursing education program for at 
least 3-4 times a year to increase nurses’ awareness and knowledge on 
VAP prevention strategies.  It is essential to explore the factors that 
contribute to the development of VAP for patients who have renal 
insufficiency and undergo intrahospital transportation in the ICU. 
Conclusion: There were significant reductions in VAP rate after 
intervention period. However the   nurses’ knowledge on VAP and the 
prevention strategies were inadequate.  Intrahospital transport and patient 
with renal insufficiency are more at risk to develop VAP.   
xvi 
 
Keywords: nurses’ knowledge, ventilator-associated pneumonia, rate of 
ventilator-associated pneumonia, intrahospital transport, and renal 
insufficiency. 
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CHAPTER 1 
INTRODUCTION 
1.1 Background 
1.1.1 Epidemiology of Ventilator-associated pneumonia 
Ventilator-associated pneumonia (VAP) is a common healthcare-
associated infection (HCAI) among patient receiving mechanical 
ventilation in Intensive Care Unit (ICU).  VAP rate varies from site to site 
and related to the duration of mechanical ventilation.  The VAP rate differs 
from countries to countries ranging from 8-28%.  In the developed country 
the VAP rate was lower (Tablan, Anderson, Besser et al., 2004; Chastre & 
Fagon, 2002).  Whilst VAP rate in Asian countries like Singapore, and 
Malaysia teaching hospital is 21.4% (Hughes, Norliza, Tan et al., 2004).  
In Thailand, the VAP rate was 40% (Danchaivijitr, Assanasen, 
Apisamthanark et al., 2005). In our ICU, unpublished VAP rate is 
approximately 10-20% (ICU surveillance, 2006; ICU surveillance, 2007), 
and similar globally [10-25%] (Mayhall, 2007; Jarvis, 2007).  Researchers 
found that VAP increases morbidity mortality; costs of hospitalization, 
duration of stay and causes physical and mental suffering to patients and 
their families (Cook, 2000 Park, 2005; Pruitt & Jacobs, 2006; Ruffell & 
Admavoca, 2008).  Patients’ with underlying factors such as elderly, 
malnutrition, diabetes, renal insufficiency, and chronic obstructive 
pulmonary disease (COPD) are prone to get VAP due to defense 
mechanisms impairment.  Poor infection control technique among health 
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care workers could influence the outcome of patients with VAP.  In order 
to prevent VAP, education of healthcare workers is important.  Education 
had been identified to be the key component in preventing VAP. This is 
due to nurses are the main care givers in ICU.  Therefore it is crucial to 
equip them with the knowledge in VAP prevention.  Danchaivijitr et al. 
(2005) in a multicenter study found that educational program reduces 
VAP rate by 50% thus effectively reduces costs and patient morbidity.  
Education, motivation and giving rewards to staff have also been shown 
to be a crucial part of VAP prevention strategies (Danchaivijitr et al., 2005; 
Cason, Tyner, Saunders et al., 2007; Huang & Wu, 2008).  Many HCAI 
prevention guidelines exist (CDC, 2009; SARI Working Group, 2011; 
Smiths Medical North America, 2009).  However, being knowledgeable 
does not mean healthcare workers could abide to the recommendations 
(Jarvis, 2007).  The VAP bundle is the recommended intervention used in 
preventing VAP. VAP bundle is a group of evidence-based practices that, 
when implemented for all patients on mechanical ventilation, results in 
tremendous reductions in the incidence of VAP (Institute of Healthcare 
Improvement, 2006).  Most of the evidence-based practices such as VAP 
bundle consist of semi-recumbent position, sedation vacation and daily 
assessment, stress ulcer prophylaxis and deep vein thrombosis 
prophylaxis (Youngquist, Carrol, Farber et al., 2007; Westwell, 2008).  
Practice of infection control by the health care workers also helps in the 
prevention of VAP (Youngquist et al., 2007; Westwell, 2008). 
 
3 
 
1.2 Problem Statement 
VAP bundle had been adopted for more than one year in the ICU, 
Hospital Universiti Sains Malaysia. However, the rates remained at 10-
20% (ICU surveillance, 2006; ICU surveillance, 2007) for two years.  This 
shows that there are gaps between the actual standard of care and 
practice. The same evidence is also reported by Sierra, Benitez, Leon et 
al. 2005.  Many countries had adopted VAP bundle concept in the 
management of VAP and had targeted zero tolerance.  VAP bundle 
concept needs to be highlighted and emphasized in order to enhance 
care workers knowledge and practices and the need for culture change 
while delivering care to the ventilated patient to prevent VAP. 
 
1.3 Operational definition 
1.3.1 Ventilator-associated Pneumonia 
VAP is defined as an inflammation of the lung parenchyma caused by 
infectious agents not present or is incubating when mechanical ventilation 
began. CDC (2009) defines VAP as a new and persistent infiltrate on 
chest radiography with at least two of the following three criteria, i. fever > 
38oC, or ii. leukopenia (< 4000 WBC/mm3) or leukocytosis (> 12,000 
WBC/mm3; and iii. purulent tracheal secretions and, an organism isolated 
from trachea aspirate or bronchoalveolar lavage (BAL) and/or organism 
isolated from blood specimen (Keeley, 2007; CDC, 2009). 
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1.3.2 Sedation vacation 
Sedation vacation is a process in which patient sedation is interrupted 
until the patient follows commands and patient is assessed for 
discontinuations of mechanical ventilation (Institute of Healthcare 
Improvement, 2006).  Sedation is withheld daily and neurological 
assessment is made to the patients.  
 
1.3.3 Ventilator-associated Pneumonia Bundle 
Ventilator-associated pneumonia bundle is a group of evidence-based 
practices that when implemented for all of the patients on mechanical 
ventilator results in significant reduction in the incidences of VAP 
(Gillespie, 2007). The theory hypothesis is, the VAP bundles improves 
ventilated patients outcome, in terms of shortening ventilator days, 
duration length of Intensive Care Unit stays, hence preventing the 
occurrence of VAP.  Therefore a few of the evidence-based interventions 
are used together in a single protocol which may provide the best 
outcome in the VAP prevention strategies (Gillespie, 2007). The VAP 
bundle includes semirecumbent position of 30-45o, sedation vacations 
and daily assessment, stress ulcer prophylaxis, deep venous thrombosis 
prophylaxis and infection control. 
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1.3.4 Oral care	
Oral care consists primarily of a mouth rinse, possessing cleansing 
(include toothbrushing, removing and oral suctioning), germicidal, or 
palliative properties (Medical Dictionary, 2007). 
 
1.3.5 Proteinaceous 
Proteinaceous is pertaining to or of the nature of protein (Medical 
Dictionary, 2007) material. 
 
1.3.6 Nosocomial infection 
The terms ‘‘nosocomial infections‘‘ is replaced by ‘‘healthcare-associated 
infections’’ (HCAIs), to reflect the changing patterns in health care delivery 
and difficulty in determining the geographic site of exposure to an 
infectious agent and/or acquisition of infection (Siegel, Rhinehart, Jackson 
et al., 2007).  
 
1.3.7 Educational program 
The educational program used in the study was modified from the CDC 
guidelines. The program was implemented to the nurses in ICU.  Four 
topics were chosen.  The lectures were delivered by anesthesiologist, a 
lecturer from the Department of Microbiology, a senior staff from the 
infection control unit (UKJEH) and the study investigator.  The lecture 
topics include introduction to body flora, epidemiology of VAP, the 
ventilator bundle, and infection control practices related to the prevention 
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of VAP (Tablan et al., 2004; Coffin, Klompas, Classen et al., 2008).  
Infection control practices topics were on standard universal precautions 
including hand hygiene. 
 
1.3.8 Healthcare-associated infection 
Healthcare-associated infection is an infection that patients obtain while 
receiving medical management for other illnesses within a healthcare 
setting (Smiths Medical North America, 2009). 
 
 
1.4 OBJECTIVES 
1.4.1 General objective	
The aim of the study is to determine the effect of an educational program 
of VAP bundle on the knowledge and practice among nurses in ICU.  
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1.4.2 Specific objectives 
1.4.2(a) To determine the rate of VAP before and after VAP bundle 
educational program. 
1.4.2(b) To evaluate the level of knowledge among nurses on Ventilator-
Associated Pneumonia (VAP) before and after VAP bundle 
educational program. 
1.4.2(c) To determine the risk factors associated with VAP. 
 
1.5 Research questions	
1.5.1 What is the nurses’ level of knowledge on VAP before and after 
the VAP bundle educational program? 
1.5.2 What is the incidence of VAP before and after the VAP-bundle 
educational program? 
1.5.3 What is the difference between the nurses’ knowledge before and 
after participating in VAP-bundle education program? 
1.5.4 What are the associated risk factors of VAP? 
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1.6 Hypothesis	
Hypothesis Null:   There are no significant differences of 
knowledge before and after participating in the 
VAP bundle educational program 
Directional Hypothesis 
Alternative:   
There are significant increase in nurses 
knowledge after participating in the VAP 
bundle educational program 
Hypothesis Null: There are no significant differences of VAP 
rate before and after the VAP bundle 
educational program 
Directional Hypothesis 
Alternative: 
There are significant reduction of VAP rate 
after the VAP bundle educational program 
Hypothesis Null: There are no significant association between 
risk factors and VAP. 
Directional Hypothesis 
Alternative: 
There are significant association between risk 
factors and VAP 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 INTRODUCTION 
Ventilator-associated pneumonia (VAP) is a common healthcare-
associated infection (HCAI) in ICU.  Guidelines on prevention and 
standard operative procedure are necessary to reduce the VAP rates.  
The approaches to prevention strategies in ICU should be multifaceted 
and multidisciplinary (Craven & Duncan, 2006).  Awareness and 
knowledge on prevention strategies are crucial to bridge the gap 
between practice and evidence-based.  Nurses are core healthcare 
workers and they are accountable in the delivering care.  It is crucial for 
them to have relevant knowledge on the epidemiology of VAP, its 
pathogenesis, the local VAP rates, risk factors, and prevention 
strategies.  This literature review focuses on the conceptual framework of 
the study, nurses’ knowledge and the causes, risk factors and prevention 
strategies of VAP.  It also includes the epidemiology, pathogenesis, and 
types of VAP; the roles of education program, and prevention strategies.  
VAP bundle are used as the preventive strategies which is the standard 
of care.  These strategies include prevention of aspiration, reducing 
numbers of organism in the oropharyngeal cavity by performing oral care 
with chlorhexidine, meticulous hand hygiene, and ventilator care. 
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2.2 Ventilator-associated pneumonia	
HCAIs are common complications in healthcare facilities worldwide 
(Jarvis, 2007).  VAP is one of the most troublesome healthcare-
associated infections (HCAI) which occurs 48 hours or more in a patient 
who is hooked on mechanical ventilator (Chastre, 2005) .  VAP was 
defined as changes of patient chest radiograph from normal at baseline 
to infiltrate, consolidation, cavitation, or pleural effusion with one of the 
following: fever > 38oC, or leukopenia (< 4000 WBC/mm3) or 
leukocytosis (> 12,000 WBC/mm3) or for adults > 70 years old, altered 
mental status and at least two of the following: change of patient 
respiratory secretion from normal to purulent or increased respiratory 
secretions or increased suctioning requirements, new onset or worsening 
cough or dyspnea, or tachypnea, rales or bronchial breath sounds, 
worsening gas exchange (e.g. O2 desaturations, e.g., PaO2/FiO2 < 240), 
increased oxygen requirements, or increased ventilator demand, and an 
organism isolated from trachea aspirate or bronchoalveolar lavage 
(BAL), or organism isolated from blood specimen (Centers for Disease 
Control and Prevention, 2009). 
 
Accurate data on the epidemiology of VAP which are limited by the lack 
of standardized criteria for its diagnosis and absence of a “gold standard” 
continue to enhance controversy about the adequacy and relevance of 
many studies in this field (Cook, 2000; Chastre & Fargo, 2002; Klompas, 
2010).  
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Pneumonia diagnosis is not simple (Alp & Voss, 2006; Schurink, van 
Nieuwenhoven, Jacobs et al., 2004).  We may be over or under-
diagnose pneumonia.  There have been disagreements regarding 
pneumonia diagnosis.  Diagnosis based on a radiographic infiltrate and 
one clinical feature alone is sensitive but not specific.  Therefore cultures 
of lower respiratory tract secretions were suggested to be included 
(Wunderink, 2000; Centers for Disease Control and Prevention (CDC), 
2009).  In addition, a bronchoalveolar lavage (BAL) or protected 
specimen brush (PSB) with quantitative analysis may be more specific 
but not practical.  Besides, invasive diagnostic techniques for BAL and 
PSB, and quantitative analysis of microbiological culture, are 
recommended and might be able to differentiate between colonization 
and infection of the respiratory tract (Soto, 2007).  On the other hand, 
bronchoscopy is risky and quantitative culture is costly and time 
consuming (Schurink, Visscher, Lucas et al., 2007; Schurink et al., 
2004).  Therefore invasive diagnostic techniques for BAL and PSB are 
not practical. These techniques are usually implemented during the study 
period and remain unused after the completion of the study.  As a result, 
these techniques have not yet become common practice in most ICUs 
(Schurink et al., 2007).  Endotracheal aspirate or sputum and/or blood 
isolate is necessary to confirm pneumonia diagnosis and is the common 
practice in Hospital in Malaysia.  BAL and PSB are rarely used for 
routine diagnostic test of suspected pneumonia cases due to the 
complication and additional costs.  
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Up to this present moment there is no gold-standard to diagnose 
pneumonia in ventilated patients (Alp & Voss, 2006).  Diagnosis based 
on a radiographic infiltrates and one clinical presentation alone may 
increase antibiotic resistant microorganism due to over-diagnose 
pneumonia.  Management of unconfirmed pneumonia case could expose 
the pneumonia patients to antibiotic resistant microorganism.  A normal 
practice is to use a broad spectrum antibiotic to cover both Gram 
negative and Gram positive organisms.  However, sometimes it is not 
specific and sensitive to the underlying organism.  To overcome this 
problem, a handheld computers, or personal digital assistants (PDAs) 
could assist in VAP diagnosis and choosing correct antibiotic for each 
patient. Trusted evidence-based guidelines are available online and 
PDAs is small and useful, and have been used widely. Sintchenko and 
co-workers study the decision support system (DSS) in confirmation of 
VAP diagnosis and choosing correct antibiotic therapy.  The criteria used 
for VAP diagnosis in the study by Sintchenko et al. (2004) are DSS and 
Clinical Pulmonary Infection Score (CPIS) plus microbiology report.  He 
found that DSS improved patient’s management and outcome.  He also 
compared the decision made by physicians using DSS (intervention 
group) with the decision of an expert’s panel based on diagnosis and 
management of VAP (control group).  He found that the decisions made 
by the physicians are in accord with the decisions of an expert panel 
from 65% to 97% (p = 0.0002) (Sintchenko et al., 2004).  This type of 
system might be expensive but it could save life as well as healthcare 
costs.  
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Fever sometimes maybe an inflammation responds of other pathology 
than pneumonia in critical the ill patients in ICU.  Alveolar infiltrate in 
patients chest radiograph might be due to acute respiratory distress 
syndrome and or atelectasis (Sharma, Maycher & Eschun, 2007; 
Wunderink, 1992).  Likewise, it is necessary to confirm pneumonia 
diagnosis with sputum and/or blood isolate (Wunderink, 2000; CDC, 
2009).  When facing with difficulty in confirming VAP it is advisable to do 
at least two or serial chest radiography as repeated chest radiographs 
sometimes had support to the confirmation of pneumonia cases (CDC, 
2009).   
 
Multiple episodes of healthcare-associated pneumonia may arise in 
critically ill patients especially in those with prolonged length of stays.  
When deciding whether to report multiple episodes of healthcare-
associated pneumonia in a single patient, the proof of resolved in 
infection for each episode must be determined.  The additional change in 
microorganism cultured alone is not indicative on a new episode of 
pneumonia.  New diagnosis of pneumonia including HAP or VAP must 
be based on new clinical manifestation of pneumonia together with chest 
radiographic confirmation or with other diagnostic test (CDC, 2009). 
 
 
The radiographic criteria used to diagnose VAP rely on subjective 
interpretations of lung parenchyma changes that might be too little, short-
lived and complicated to differentiate in an ICU patient.  These opacities 
often do not follow typical anatomic distribution and are often masked by 
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pleural effusions, atelectasis, pulmonary oedema, or postoperative 
changes (Halpern, Hale, Sepkowitz et al., 2012).  Therefore experts are 
required to analyze patient’s chest radiograph to confirm diagnosis 
especially in difficult cases.  
 
Pneumonia may have a brisk onset and development, but are slow in 
resolving.  Therefore the pneumonic changes on chest radiograph may 
be delayed in resolving too, sometimes up to few weeks.  Therefore, 
rapid radiographic resolution may suggest that the patient does not have 
pneumonia, but perhaps a non-infectious process such as atelectasis or 
congestive heart failure.  The radiographic pneumonic changes can be 
described in diverse of way such as “air-space disease”, “focal 
opacification”, or “patchy areas of increased density”.  Although perhaps 
these are not specifically delineated as pneumonia by the radiologist, in 
the appropriate clinical setting these alternative descriptive wordings 
should be seriously considered as potentially positive findings (CDC, 
2009).  
 
If there are doubts even after the serial chest radiograph, a computed 
tomography should be opted for as it is mandatory in unresolved cases 
(Sharma et al., 2007).  Over-diagnose pneumonia may expose patient to 
unnecessary antibiotic usage which is equivalent to cost, increase 
multidrug resistance organism, and increase in length of stay (Alp & 
Voss, 2006).   
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Therefore ICU nurses should have knowledge on pneumonia criteria to 
be able to identify VAP and justify the prescribed antibiotic.  Invasive 
ventilation, (Tablan et al., 2004) and accidental extubation or reintubation 
ought to be avoided (Epstein, 2002) to prevent VAP.  
 
Patients who are confirmed to be extubated must pass breathing trial 
which is designed to assess for upper airway obstruction, secretion 
volume, and the effectiveness of cough.  Consequently, delay in 
reestablishing ventilator support after a fail extubation is associated with 
increased mortality.  Healthcare workers have to be alert to any slight 
changes from their patient to anticipate extubation failure (Epstein, 
2002).  
 
Drugs are commonly administered in ICU to relieve anxiety and pain, 
such as sedative and analgesic (Mehta, Burry, Fischer et al., 2006).  
Analgesia administration for post-operative patient who are on sedation 
vacation is essential to prevent discomfort and restlessness, which could 
lead to unintentional extubation (Epstein, 2002).  Discomfort may lead to 
restlessness and could result in unsecure endotracheal tube and 
dislodgment of the tube (self-extubation or accidental extubation).  The 
endotracheal tube which is inserted into the patient’s trachea is 
connected to a mechanical ventilator to assist and support patient's 
ventilation.  Therefore a dislodgment of the endotracheal tube could be 
fatal to the mechanical ventilated ICU patients and should be avoided. 
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Extubation failure is associated with a poor prognosis usually follow an 
obvious decline in patient’s clinical presentation.  Indeed, if it is clear that 
reintubation is necessary (Thille, Harrois, Schortgen et al., 2011), if 
possible non-invasive ventilation may be the mode of choice (Alp & 
Voss, 2006). 
 
A study reported that the rates for reintubation were 18% 26 out of 168 
planned extubation required reintubation within 72 hours and another 
four patients required reintubation after 72 hours.  The reasons for 
reintubation include acute respiratory failure [n = 19, 73%], coma [n = 4, 
15%], and shock [n = 3, 12%] (Thille et al., 2011). 
 
VAP rate varies from one location to another, and is related to the 
duration of mechanical ventilation. Longer duration of mechanical 
ventilator is proportional to higher VAP incidence rate.  VAP rates among 
ICU patients differ from study to study i.e.  8-28%; 10-25%, 10-20% and 
15%, (Chastre & Fagon, 2002; Mayhall, 2007; Jarvis, 2007; Safdar, 
Crnich & Maki, 2005a; Tablan et al., 2004) respectively.  Most 
researchers found that their VAP rates is approximately 10-20% 
(Mayhall, 2007; Jarvis, 2007; Safdar et al., 2005a; Tablan et al., 2004) as 
opposed to a multicenter study in Thailand which reported a higher VAP 
rates of 40% (Danchaivijitr et al., 2005).  VAP rates are lower in 
developed countries compared to developing counties.  Much has been 
debated regarding achieving zero tolerance of VAP rates.  All clinician 
involved in delivering care to patients in ICU should have access to their 
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local VAP rates to ensure that they understand what the data means to 
their local situations. 
 
2.3 Pathogenesis	
Understanding the pathogenesis of VAP is crucial in the prevention 
strategies.  The pathogenesis of VAP is multifactorial (Bassi & Torres, 
2011).  VAP may occur by four ways: haematogenous spread from a 
local infection; contiguous spread; inhalation of infectious aerosols, 
ventilators from nebulizers, respiratory equipment, and aspiration from 
gastric colonization, oropharyngeal secretion, gastro-esophageal reflux 
and enteral feeding (Kim, Koziol-Mclain, Wilson et al., 2007; Alp & Voss, 
2006).   Pathogen colonization in oropharynx and gastrointestinal tract 
are the main source of aspirates (Paju & Scannapieco, 2007; Augustyn, 
2007; Safdar, Crnich & Maki, 2005b). 
 
Oral bacteria, poor oral hygiene, and periodontitis could influence the 
VAP rate (Paju & Scannapieco, 2007).  Endotracheal intubation is 
prerequisite for the development to VAP (Bonten, Kollef & Hall, 2004). It 
causes impairment to the pulmonary defense mechanisms, therefore 
endotracheal intubation and mechanical ventilation should be avoided 
(Tablan et al., 2004) whenever possible.  Non-invasive positive-pressure 
ventilation with facial mask could be used instead (Tablan et al., 2004).  
Endotracheal tube will provide a direct route for oxygen along with 
organisms to enter the lungs.  The normal function of the upper 
respiratory tract is as physical and mechanical barrier in concert with the 
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gastric acid as a chemical barrier (Fahy & Dickey, 2010) to protect the 
lungs from organisms and dusts.  The air which enters the nose is warm 
and moist before entering the lungs (Voynow & Rubin, 2009).  
Endotracheal tube will push away the normal defense system and 
patients are susceptible to VAP.  Once VAP sets in, it could lead to 
septicemia and increase morbidity and mortality.  VAP is a burden to the 
healthcare workers, patients and their families.  VAP is divided into two 
types which are weighed by the durations of mechanical ventilation.  The 
write-up below is on the description of the two types of VAP.  
 
2.4 Types of ventilator-associated pneumonia	
Determining the type of VAP can help identify the causative organism 
thus, guide antibiotic therapy (Pruitt & Jacobs, 2008).  VAP is divided into 
two types, the early-onset VAP or type 1 and the late-onset or type 2.  
Distinguishing the types of VAP is essential since the early-onset has 
better prognosis compares to the late-onset.  This is because the 
causative organism in late onset usually more resistant to certain 
antibiotics.  The responsible organisms of the early-onset VAP is often 
the same as the community-acquired pneumonia (CAP).  These 
organisms usually are Streptococcus pneumoniae, Haemophilus 
influenzae, and Moraxella pneumonia (Pruitt & Jacobs, 2008).  The 
early-onset VAP occurs during the first four days of mechanical 
ventilation and this organism is easily treated and easily identified 
compared to these of the late-onset VAP (Davies, 2009; Keeley, 2007). 
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The late-onset VAP occurs five days or more after the start of 
mechanical ventilation.  It is a healthcare acquired infection and the 
common organisms are Staphylococcus aureus, Acinetobacter baumanii, 
Pseudomonas aeruginosa, Klebsiella pneumoniae and Entrobacter 
species (Pruitt & Jacobs, 2008).  These are well known pathogens and 
are multi-drug resistant organism and require specific antibiotics, thus 
they have grave prognosis compared to the early-onset.  VAP is divided 
into two types for ease of identification of caustic organisms and 
antibiotic therapy.  The VAP risk factors will be discussed in the next 
subheading.  
 
2.5 Risk Factors of ventilator-associated pneumonia	
Identifying risk factors for VAP is vital in its prevention strategies.  Risk 
factors provide information about the chance of lung infection developing 
in individuals and population.  Thus, knowing the risk factor could aid and 
support healthcare workers in the prevention strategies against 
pneumonia (Chastre & Fargon, 2002).  Patient who developed VAP have 
certain risk factors (Davies, 2009; Schleder, Stott & Lloyd, 2002), such 
as conditions that increase the risk of colonization by pathogens in the 
oral cavity and previous antibiotic therapy (Chlebicki & Safdar, 2007; 
Schleder et al., 2002).  These critically ill patients with the underlying risk 
factors are more susceptible than other patients. 
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2.6 Implication of ventilator-associated pneumonia 
2.6.1 Morbidity	
VAP has implication on morbidity and mortality.  VAP causes prolonged 
ventilation duration, increases length of stay in ICU and hospital, 
psychological sufferings to patient (Tejerina, Frutos-Vivar, Restrepo et 
al., 2006; Chavez, Delahanty, Cahill, et al., 2005; Myhren, Tøien, 
Karlsson et al., 2009) and family.  ICU patients are (1:10) at risk for 
developing post traumatic syndrome disorder (PTSD).  The PTSD could 
be reduced with changes within the ICU and patient support after ICU 
discharge (Jones, Bäckman, Capuzzo et al., 2007).  VAP is associated 
with prolonged length of stay which increases burden on health care 
resources (Rotstein, Evans, Born et al., 2008). 
 
Contribution of VAP to mortality has been a controversial subject.  
Researchers found that mortality is related to underlying and severity of 
the disease (Nguile-Makao, Zahar, Francais et al., 2010; Bonten et al., 
2004; Rello, Jubert, Vallés et al., 1996).  VAP is associated with mortality 
equally amongst patients with shock, acute renal failure, and worsening 
hypoxemia during ventilation period (Tejerina et al., 2006).  However, at 
least one systemic review has shown that VAP is not related to in trauma 
and acute respiratory distress syndrome cases (Melsen, Rovers & 
Bonten, 2008).  VAP could lead to bacteremia, septic shock, sepsis 
pleural effusion, and multi-organ failure (Narang, 2008), VAP is a 
continuous threat to mechanical ventilated patients if the vicious cycle 
chain could not be broken (Dodek, Keenan, Cook et al., 2004).   
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In order to reduce VAP rate, continuous educational program is 
necessary and potent tool in any prevention strategies for VAP (Cason et 
al., 2007; Danchaivijitr et al., 2005; Tablan et al., 2004). 
 
2.6.2  Prevention	
An important risk factor in VAP patient is the risk of aspiration. 
Conditions that increase the risk of aspiration that has been discuss 
repeatedly are being in supine position (Apisarnthanarak, Pinitchai, 
Thonghubethe et al., 2007; Metheny, Clouse, Chang et al., 2006), 
distended abdomen or gastric over distension, bacterial colonization in 
the upper airway and stomach (Burns, 2007; Paju & Scannapieco, 2007), 
history of stress ulcer and stress ulcers, nasotracheal intubation, 
decreased level of consciousness, and poor maintenance of 
endotracheal cuff  pressure (Cook, Attia, Weaver et al., 2000a), 
presence of a nasogastric tube (NGT)  (Apisarnthanarak et al., 2007), 
and endotracheal intubation (Schleder et al., 2002).  The presence of 
tubes in the airway such as ETT and NGT interferes in cough and 
swallowing mechanisms and often leads to aspiration and ultimately VAP 
(Trieger, 2004).  Patients own intrinsic factors such as extreme age, 
malnutrition, diabetes, renal insufficiency and, chronic obstructive 
pulmonary disease (COPD) (Aspisarunthanarak et al., 2007) will impair 
defense mechanisms.  At least one study identify trauma and male 
gender are also risk factors for VAP (Metheny, Schallom, Oliver et al., 
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2008).  Severe trauma patients are most likely need longer duration of 
stay in ICU due to head injury and internal organ injury.  Most 
researchers have identified that poor infection control techniques by 
healthcare workers contribute to VAP (Pruitt & Jacobs, 2006; Tablan et 
al., 2004).  Ineffective hand hygiene and using ungloved hands while 
managing the respiratory secretions or equipment soiled with respiratory 
secretions also lead to VAP (Pruitt & Jacobs, 2006).  Meanwhile, 
sucralfate used were associated with an increased risk of VAP during 
ARDS (adjusted OR: 1.206; 95% CI: 1.095 to 1.328, p = 0.0002) 
(Markowicz, Wolff, Djedaini et al., 2000). 
 
2.6.3 Educational program 
Continuous nursing educational program is crucial and an effective tool 
in prevention of VAP (Cason et al., 2007; Danchaivijitr et al., 2005; 
Tablan et al., 2004).  Study on nurse’s knowledge related to VAP 
prevention is limited.  Research elsewhere had found that experience 
does not correlate with quality of care.  Meta-analysis of 32 out of the 62 
(52%) published report showed declining tendency in performance of 
physicians with increasing years in practice for all outcomes assessed.  
Physicians who have been in practice longer maybe at risk for providing 
lower-quality care (Choudhry, Fletcher & Soumerai, 2005).  Therefore, 
experienced healthcare workers may need quality improvement 
interventions in terms of update in knowledge to ensure quality care are 
delivered to patients in ICU.  However, dissimilarity reported by Blot et al. 
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(2007) in a survey conducted during the annual congress of the Flemish 
Society for Critical Care Nurses.  The study showed that the average 
knowledge level was higher among more experienced nurses (> 1 year 
experience) and those holding a special degree in emergency and 
intensive care (Blot, Labeau, Vandijck et al., 2007). 
 
Decision is based on individual optimal knowledge, skills, opinions, 
attitudes, values, routines, or personalities (Kaier, Wilson, Hulscher et 
al., 2011).  Therefore all the healthcare workers are educated.  However, 
healthcare workers with deviant attitudes and values could hamper 
change, patient care and outcome. 
 
Awareness (Aitken, Williams, Harvey et al., 2009), and education are 
essential in any prevention program crucial for processes of change 
(Aitken et al., 2011).  All critical care units should have continuous 
educational program in infection prevention and control for all healthcare 
workers delivering care for patients using mechanical ventilation (Tablan 
et al., 2004).  Education is the key in preventing VAP (Smith Medical 
North America, 2009).  Most researches recommended educational 
intervention delivered to nurses and respiratory care practitioners to 
reduce VAP rates in the ICU setting (Babcock, Zack, Garrison et al., 
2004; Tablan et al., 2004).  Healthcare workers in ICU especially nurses 
are always with their patients, providing care and fulfilling their needs.  
Therefore it is crucial for them to be knowledgeable in the prevention of 
VAP.  The 2003 CDC guidelines recommended staff education on local 
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epidemiology and infection control practices related to the prevention of 
VAP (SARI working group, 2011; Cason et al., 2007; Tablan et al., 
2004).  At least one multicenter study proved that educational program 
reduces VAP rate by 50%, thus effectively reduces costs and patient 
morbidity (Danchaivijitr et al., 2005).  A study by Needleeman et al. 
(2004) reported that increase numbers of hours spent by nurses 
delivering care are statistically significant associated with a shorter 
length of stay in ICU, p < 0.001 (Needleman, Buerhaus, Mattke et al., 
2004). This issue had been confirmed by Rello et al. (2010) the time 
allocated by nurses delivering care is significantly associated with better 
health for hospitalized patients (Rello, Lode, Cornaglia et al., 2010).  
Education and training (Rello et al., 2010; Bonten et al., 2004), 
motivation (Blot, Vandijck & Labeau, 2008) and rewarding staff (Huang & 
Wu, 2008) have also been shown to be an essential part of VAP 
prevention strategies.  Many HCAI prevention guidelines exist (Abbott, 
Dremsa, Stewart et al., 2006; Tablan et al., 2004).  However, the 
concern and challenge remains to ensure clinician to accept and practice 
the recommendations (Jarvis, 2007).   
 
All ventilated patients must be on written order or standard protocol, for 
instance, all ventilated patients should be placed on semirecumbent 
position with additional order specifying angle of head-of-bed to be more 
than 30 to 45o, likewise, intensivists, head-nurse and senior nurse must 
reinforce the importance of keeping and abiding to the guideline and 
constantly reminding nurses that patient should be in semirecumbent 
